Saturday, January 14, 2017 10:54:58 AM
I thought the company looked good when I just knew about their MNP Platform and Estrasorb but the nano-cannabinoid research and the info posted on the reformulated API's takes this to a whole other level.
I could not find many companies out there conducting transdermal or nano-cannabinoid research, I'd say their closest competitor would probably be Zynerba Pharmaceuticals (NASDAQ: ZYNE), In many ways I feel like NewGen actually looks better than ZYNE though.
ZYNE did a NASDAQ IPO so they are on a better exchange and have more cash, however, at least $100M has been invested into developing NewGens MNP Platform and it has FAR more flexibility vs simply the two products that ZYNE is developing.
I think this is going to be a company to watch in 2017, if they can manage to keep dilution at a minimum and not enter into any toxic convertible financing deals this could be pretty epic IMO.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM